Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen R Rabin

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|April 13, 2012
Attacking remaining challenges in childhood leukemiaKaren R Rabin
The Lancet. Haematology|September 24, 2021
Risk stratification for Down syndrome and acute lymphocytic leukaemia: one size does not fit allKaren R Rabin
JAMA Oncology|January 27, 2022
Genetic Ancestry and Childhood Acute Lymphoblastic Leukemia Subtypes and Outcomes in the Genomic EraKaren R Rabin
JAMA Oncology|January 17, 2020
Optimizing Targeted Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaKaren R Rabin
Blood|August 24, 2023
Insights into the genomics of iAMP21-ALLKaren R Rabin
Blood|April 8, 2017
Self-reported adherence in ALL: true or false?Karen R Rabin
Blood|August 16, 2014
First do no harm: infectious deaths in pediatric ALLKaren R Rabin
Current Oncology Reports|June 13, 2013
The adolescent and young adult with cancer: state of the art-- acute leukemiasM Monica Gramatges, Karen R Rabin
Oncology (Williston Park, N.Y.)|May 31, 2011
Management strategies in acute lymphoblastic leukemiaKaren R Rabin, David G Poplack
The Oncologist|January 30, 2009
Malignancy in children with trisomy 21Karen R Rabin, James A Whitlock
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|April 13, 2012
Attacking remaining challenges in childhood leukemiaKaren R Rabin
The Lancet. Haematology|September 24, 2021
Risk stratification for Down syndrome and acute lymphocytic leukaemia: one size does not fit allKaren R Rabin
JAMA Oncology|January 27, 2022
Genetic Ancestry and Childhood Acute Lymphoblastic Leukemia Subtypes and Outcomes in the Genomic EraKaren R Rabin
JAMA Oncology|January 17, 2020
Optimizing Targeted Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaKaren R Rabin
Blood|August 24, 2023
Insights into the genomics of iAMP21-ALLKaren R Rabin
Blood|April 8, 2017
Self-reported adherence in ALL: true or false?Karen R Rabin
Blood|August 16, 2014
First do no harm: infectious deaths in pediatric ALLKaren R Rabin
Current Oncology Reports|June 13, 2013
The adolescent and young adult with cancer: state of the art-- acute leukemiasM Monica Gramatges, Karen R Rabin
Oncology (Williston Park, N.Y.)|May 31, 2011
Management strategies in acute lymphoblastic leukemiaKaren R Rabin, David G Poplack
The Oncologist|January 30, 2009
Malignancy in children with trisomy 21Karen R Rabin, James A Whitlock
Pageof 13